• Home
• Fetal Growth Restriction
  • What is FGR?
  • What Causes FGR?
  • The Evidence so far
  • How Gene Therapy Works
• Prospective Study
  • Prospective Study Overview
  • Interview Study
  • EVERREST Update Event
  • Data Protection
• Clinical Trial
  • Assessing Safety
  • Ethical Approval
  • Regulatory Approval
• The Project
  • Objectives
  • WP 1 - Pre-clinical toxicology
  • WP 2 - Bioethics study
  • WP 3 - Clinical Study Design
  • WP 4 - Ethical and Regulatory Approval
  • WP 5 - Phase I/II Clinical Study
  • WP 6 - Exploitation and Dissemination
  • WP 7 - Project Management
  • Ethical and Safety Monitoring & Clinical Trial Summary
• The Consortium
  • University College London
  • FinVector Vision Therapies
  • Queen Mary and Westfield College.
  • University of Eastern Finland
  • University Medical Center Hamburg-Eppendorf
  • Maternal-Fetal Unit Hospital Clinic de Barcelona
  • Lund University
  • University College London Hospital NHS Foundation Trust
• Links
• News

 

Work Package - 1

Pre-Clinical Toxicology

Objectives: To complete the pre-clinical toxicology programme to assess the safety of the Investigational Product that will be manufactured and to establish the doses to be used in the clinical study.